Nanodiamond delivery circumvents tumor resistance to doxorubicin
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,General Medicine
Link
http://www.nature.com/articles/aps201158.pdf
Reference13 articles.
1. Giaccone G, Linn SC, Pinedo HM . Multidrug resistance in breast cancer: mechanisms, strategies. Eur J Cancer 1995; 31A: S15–7.
2. Chenivesse X, Franco D, Brechot C . MDR1 (multidrug resistance) gene expression in human primary liver cancer and cirrhosis. J Hepatol 1993; 18: 168–72.
3. Gillet JP, Gottesman MM . Mechanisms of multidrug resistance in cancer. Methods Mol Biol 2010; 596: 47–76.
4. Liang XJ, Meng H, Wang Y, He H, Meng J, Lu J, et al. Metallofullerene nanoparticles circumvent tumor resistance to cisplatin by reactivating endocytosis. Proc Natl Acad Sci USA 2010; 107: 7449–54.
5. Krishna R, Mayer LD . Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs. Eur J Pharm Sci 2000; 11: 265–83.
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Multifunctional nanodiamonds as emerging platforms for cancer treatment, and targeted delivery of genetic factors and protein medications—a review;Journal of Materials Science;2022-04-25
2. Safety evaluation of nanodiamond-doxorubicin complexes in a Naïve Beagle canine model using hematologic, histological, and urine analysis;Nano Research;2021-09-18
3. Anticancer medicinal plants used by Moroccan people: Ethnobotanical, preclinical, phytochemical and clinical evidence;Journal of Ethnopharmacology;2021-02
4. A Functionalized Polydopamine Theranostic Nanoprobe for Efficient Imaging of miRNA-21 and In Vivo Synergetic Cancer Therapy;Molecular Therapy - Nucleic Acids;2020-12
5. Tamoxifen-Loaded Nanodiamonds as a Potential Nanosystem for Drug Delivery to Breast Cancer Cells;Nanoscience and Nanotechnology Letters;2019-08-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3